Become the voice of data science at one of the world’s leading research-driven pharmaceutical companies.

Interested in pushing the boundaries of model-informed drug development? Want to play a part in reinventing clinical drug development?

Your goal is to accelerate clinical development timelines. Doing this will contribute to the discovery of breakthrough therapies, ultimately improving human health and creating value for patients.

As the most senior member of the team, you’ll also shape and drive the data and data analysis strategy. You’ll be a positive influence on the culture – someone people can turn to.

And in this highly-visible role, there’s always opportunity for career growth.

What’s the job?

If you’re used to working in a silo, this role couldn’t be more different.

Joining a 33-strong Pharmacometrics function within the Data Science group, the work is focused across specific therapeutic areas such as oncology, inflammation, cardiology, respiratory diseases and diseases of the central nervous system.

You’d be supporting projects from one clinical phase to the next, identifying opportunities where Pharmacometricss can further the company’s understanding of pharmacological activity, efficacy and safety.

You’ll even have the satisfaction of seeing projects develop from the very start –before even first-in-human trials.

From there, you’ll be involved in defining the decision points after each phase of the study and support projects through to successful regulatory approval and beyond.

The job is based in either Ingelheim or Biberach, with flexibility to work up to 75% remotely.

Working alongside intelligent colleagues from diverse cultures and professional backgrounds, you can contribute to a wealth of initiatives. As a key team member, you’ll also represent Pharmacometrics both internally and externally.

Key responsibilities will include:

• Developing the pharmacometrics strategy and contributing to the asset evidence plan for clinical development projects.

• Planning and carrying out quantitative analyses to support internal decision making, disease understanding and successful approval. For example: pharmacokinetics/pharmacodynamics, exposure-response, disease progression modelling, model-based meta-analysis.

• Continuously evaluating novel pharmacometrics approaches and driving their development – this could be pharmacometrics tools, software, hardware or related business processes.

• Leading and contributing to internal and external initiatives in your therapeutic area of expertise; developing links with key opinion leaders both in pharmacometrics and data science in general.

What you’ll add

You’ll have been exposed to modelling, whether in clinical OR preclinical drug development in the pharmaceutical industry, regulatory agencies or academia. If you have the right industry knowledge, you could also join with a background in pharmacy, physics or system engineering.

Alongside a Master’s or PhD in a relevant field, you’ll also have a strong level of experience in Pharmacometrics/Data Science.

If you’re a leader, you may either be keen to drive the strategy for a particular therapeutic area where you have strong knowledge of pharmacometrics approaches.

Or, if you’re someone who’s passionate about scientific progress, then you’ll be interested in implementing new approaches.

You’ll also add:

• Non-linear mixed-effects modelling (NLME) experience using NONMEM or Monolix.

• R programming experience would be useful, especially in: data processing, running simulations, plotting, shiny apps etc (MATLAB or SAS also considered).

• Coaching junior colleagues in specific scientific approaches.

About the business

You’d be based at one of the largest European pharmaceutical facilities. Housing Research, Development and Manufacturing for small molecules and biopharmaceuticals, it’s home to some of the world’s best pharmaceutical minds developing products in a sharing and informal community. This unique spirit and expertise fuel them to keep innovating and creating value for their patients and customers.

The company is making a significant investment in the digital transformation of their Innovation Unit. Spanning research, pre-clinical development, translational medicine and clinical pharmacology, the Unit’s aim is to enable cutting-edge digital sciences.

Find out more

To find out more about the business, the benefits and the job, click the enquire today button.